|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
2/24/22 Iovance Biotherapeutics, Inc. 10-K 12/31/21 79:10M Toppan Merrill Bridge/FA
1/19/22 McPeak Merrill A 5 Director² 1:5K Iovance Biotherapeutics, Inc. Toppan Merrill/FA
____________ | ¹ | Filing/Form Types: | | 5 | Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 { The Filer is an Insider² of the Issuer }. | | 10-K | Annual Report — Form 10-K. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|